296 related articles for article (PubMed ID: 28762013)
1. The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.
Pishkari S; Paryan M; Hashemi M; Baldini E; Mohammadi-Yeganeh S
J Endocrinol Invest; 2018 Mar; 41(3):269-283. PubMed ID: 28762013
[TBL] [Abstract][Full Text] [Related]
2. Expression of MicroRNAs in Thyroid Carcinoma.
Zhu G; Xie L; Miller D
Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
[TBL] [Abstract][Full Text] [Related]
4. Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review.
Chruścik A; Lam AK
Exp Mol Pathol; 2015 Dec; 99(3):393-8. PubMed ID: 26321247
[TBL] [Abstract][Full Text] [Related]
5. Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications.
Menon MP; Khan A
J Clin Pathol; 2009 Nov; 62(11):978-85. PubMed ID: 19625289
[TBL] [Abstract][Full Text] [Related]
6. Total circulating cell-free miRNA in plasma as a predictive biomarker of the thyroid diseases.
Caglar O; Cayir A
J Cell Biochem; 2019 Jun; 120(6):9016-9022. PubMed ID: 30506793
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
Pallante P; Visone R; Croce CM; Fusco A
Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
[TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Geraldo MV; Kimura ET
PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
[TBL] [Abstract][Full Text] [Related]
9. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
10. Modeling thyroid cancer in the mouse.
Zhu XG; Cheng SY
Horm Metab Res; 2009 Jun; 41(6):488-99. PubMed ID: 19358084
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in thyroid cancer with focus on medullary thyroid carcinoma: potential therapeutic targets and diagnostic/prognostic markers and web based tools.
Shakiba E; Boroomand S; Kheradmand Kia S; Hedayati M
Oncol Res; 2024; 32(6):1011-1019. PubMed ID: 38827323
[TBL] [Abstract][Full Text] [Related]
12. Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review, meta-analysis, and experimental validation.
Hu Y; Wang H; Chen E; Xu Z; Chen B; Lu G
Cancer Med; 2016 Sep; 5(9):2602-14. PubMed ID: 27465286
[TBL] [Abstract][Full Text] [Related]
13. [Molecular Aspects of Thyroid Tumors with Emphasis on MicroRNA and Their Clinical Implications].
Ludvíková M; Kholová I; Kalfeřt D
Klin Onkol; 2017; 30(3):167-174. PubMed ID: 28612612
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy: a new hope for thyroid carcinomas.
Perri F; Pezzullo L; Chiofalo MG; Lastoria S; Di Gennaro F; Scarpati GD; Caponigro F
Crit Rev Oncol Hematol; 2015 Apr; 94(1):55-63. PubMed ID: 25465739
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
Min XS; Huang P; Liu X; Dong C; Jiang XL; Yuan ZT; Mao LF; Chang S
Tumour Biol; 2015 Sep; 36(10):7457-63. PubMed ID: 25908172
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
Abraham D; Jackson N; Gundara JS; Zhao J; Gill AJ; Delbridge L; Robinson BG; Sidhu SB
Clin Cancer Res; 2011 Jul; 17(14):4772-81. PubMed ID: 21622722
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA role in thyroid cancer pathogenesis.
Zhang X; Mao H; Lv Z
Front Biosci (Landmark Ed); 2013 Jan; 18(2):734-9. PubMed ID: 23276957
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of microRNA expression in thyroid tumors.
Yuan ZM; Yang ZL; Zheng Q
J Zhejiang Univ Sci B; 2014 Mar; 15(3):212-24. PubMed ID: 24599686
[TBL] [Abstract][Full Text] [Related]
19. Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.
Schwertheim S; Sheu SY; Worm K; Grabellus F; Schmid KW
Horm Metab Res; 2009 Jun; 41(6):475-81. PubMed ID: 19370508
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNAs in endocrine cancer metastasis.
Lima CR; Gomes CC; Santos MF
Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
